Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CADDY reminder function study for flexible extended drospirenone + ethinyl estradiol oral contraception
2010-019902-17Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ethinyl estradiol + drospirenone in contraception (2 arms), sponsored by Bayer. Primary endpoint: Mean daily delay of tablet release. Started Oct 2010; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on 2010-019902-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019902-17.